Exciting new research unveils the benefits of Hyperbaric Oxygen Therapy (HBOT) in facilitating successful UCB transplants and engraftment. Stem cells, vital for blood-related cancer treatments, are often sourced from umbilical cord blood (UCB) when no donor match is available. UCB offers favorable outcomes with minimal risks in transplants. However, engraftment, the process where transplanted blood-making cells adapt and thrive in their new environment, poses challenges......